Your browser doesn't support javascript.
loading
Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period.
King, Jennifer P; Chung, Jessie R; Donahue, James G; Martin, Emily T; Leis, Aleda M; Monto, Arnold S; Gaglani, Manjusha; Dunnigan, Kayan; Raiyani, Chandni; Saydah, Sharon; Flannery, Brendan; Belongia, Edward A.
Afiliação
  • King JP; Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, 1000 North Oak Avenue ML2, Marshfield, WI, 54449, USA. King.jennifer@marshfieldresearch.org.
  • Chung JR; Influenza Division, US Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop H24-7, Atlanta, GA, 30329, USA. jchung@cdc.gov.
  • Donahue JG; Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, 1000 North Oak Avenue ML2, Marshfield, WI, 54449, USA.
  • Martin ET; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
  • Leis AM; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
  • Monto AS; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
  • Gaglani M; Baylor Scott & White Health, Temple, TX, USA.
  • Dunnigan K; Texas A&M University College of Medicine, Temple, TX, USA.
  • Raiyani C; Baylor Scott & White Research Institute, Temple, TX, USA.
  • Saydah S; Baylor Scott & White Research Institute, Temple, TX, USA.
  • Flannery B; Coronavirus and Other Respiratory Viruses Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Belongia EA; Influenza Division, US Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop H24-7, Atlanta, GA, 30329, USA.
BMC Infect Dis ; 24(1): 300, 2024 Mar 08.
Article em En | MEDLINE | ID: mdl-38454352
ABSTRACT

BACKGROUND:

Symptoms of COVID-19 including fatigue and dyspnea, may persist for weeks to months after SARS-CoV-2 infection. This study compared self-reported disability among SARS-CoV-2-positive and negative persons with mild to moderate COVID-19-like illness who presented for outpatient care before widespread COVID-19 vaccination.

METHODS:

Unvaccinated adults with COVID-19-like illness enrolled within 10 days of illness onset at three US Flu Vaccine Effectiveness Network sites were tested for SARS-CoV-2 by molecular assay. Enrollees completed an enrollment questionnaire and two follow-up surveys (7-24 days and 2-7 months after illness onset) online or by phone to assess illness characteristics and health status. The second follow-up survey included questions measuring global health, physical function, fatigue, and dyspnea. Scores in the four domains were compared by participants' SARS-CoV-2 test results in univariate analysis and multivariable Gamma regression.

RESULTS:

During September 22, 2020 - February 13, 2021, 2712 eligible adults were enrolled, 1541 completed the first follow-up survey, and 650 completed the second follow-up survey. SARS-CoV-2-positive participants were more likely to report fever at acute illness but were otherwise comparable to SARS-CoV-2-negative participants. At first follow-up, SARS-CoV-2-positive participants were less likely to have reported fully or mostly recovered from their illness compared to SARS-CoV-2-negative participants. At second follow-up, no differences by SARS-CoV-2 test results were detected in the four domains in the multivariable model.

CONCLUSION:

Self-reported disability was similar among outpatient SARS-CoV-2-positive and -negative adults 2-7 months after illness onset.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos